COVID - 19: Clinical Trials

3 trials for COVID - 19, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 not yet recruiting. 3 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 13Completed 2, Not yet recruiting 1

Follow COVID - 19: new trials by email Literature Review of COVID - 19 trials Research Report on COVID - 19

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Immunogenicity Evaluation of the Recombinant Flagellin Protein Adjuvant
KFD1(0µg ), KFD1(20µg), KFD1(40µg) - COVID - 19
Early Phase 1Not yet recruitingShanghai Public Health Clinical Center602024-12-302025-01-10
Immunogenicity of COVID-19 Vaccine Co-administration With Influenza Vaccine in Healthy Volunteers
Bivalent mRNA SARS-CoV-2 vaccine, Quardrivalent influenza vaccine - COVID - 19
Early Phase 1CompletedPrince of Songkla University362024-03-012025-12-04
Vitamin E Supplementation As Adjunctive Therapy To Lower Inflammation In COVID-19 Patients
Patients were randomly assigned, under a double-blind design, α-Tocopherol group (n = 22) - COVID - 19
Early Phase 1CompletedUniversidad Veracruzana562020-09-272026-02-17

Narrower conditions

COVID-19 (3)  ·  Influenza, Human (1)

Broader conditions

Coronaviridae Infections (3)  ·  Coronavirus Infections (3)  ·  Infections (3)  ·  Lung Diseases (3)  ·  Nidovirales Infections (3)  ·  Pneumonia (3)  ·  Pneumonia, Viral (3)  ·  RNA Virus Infections (3)  ·  Respiratory Tract Diseases (3)  ·  Respiratory Tract Infections (3)  ·  Virus Diseases (3)  ·  Orthomyxoviridae Infections (1)

Sponsors

Prince of Songkla University (1)  ·  Shanghai Public Health Clinical Center (1)  ·  Universidad Veracruzana (1)

Countries

China (1)  ·  Mexico (1)  ·  Thailand (1)

Top investigators

Sarunyou Chusri, M.D., Ph.D. (1)